ARID1A and endometrial carcinoma: In addition, despite the mostly unknown genetic basis, in 14%–22% of uterine endometrial clear cell carcinoma (UCCC), a rare disease that accounts for <5% of all endometrial carcinomas, ARID1A expression is also found to be downregulated (39).